NCT00396851

Brief Summary

The study plans to compare the glucose-lowering effect of gurmar, a herbal preparation, with metformin in patients with type 2 diabetes

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 8, 2006

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2007

Completed
Last Updated

November 8, 2006

Status Verified

November 1, 2006

First QC Date

November 6, 2006

Last Update Submit

November 6, 2006

Conditions

Type 2 Diabetes Mellitus

Interventions

GurmarDRUG
MetforminDRUG

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly detected type 2 diabetes
  • Fasting plasma glucose \>126mg/dl
  • HbA1c \> 7%

You may not qualify if:

  • Serious comorbid illnesss
  • History of drug abuse
  • History of recent weight loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIMER

Chandigarh, 160012, India

Location

Related Publications (1)

  • Gnesin F, Thuesen ACB, Kahler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020 Jun 5;6(6):CD012906. doi: 10.1002/14651858.CD012906.pub2.

    PMID: 32501595DERIVED

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Metformin

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic Chemicals

Study Officials

  • Deepak Bhasin, MD,DM

    Post Graduate Institute of Medical Education and Research, Chandigarh

    STUDY CHAIR

  • Anil Bhansali

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Samir Malhotra, MD, DM

CONTACT

+91-172-27552433samirmalhotra345@yahoo.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 6, 2006

First Posted

November 8, 2006

Study Start

January 1, 2007

Last Updated

November 8, 2006

Record last verified: 2006-11

Locations

IN(1)